Furthermore, certain oncogenes like EGFR, PTEN, and TTN had a high frequency of mutations in the group with a high copper metabolism-associated biomarker, suggesting their potential relevance for therapeutic intervention in GBM (26) (27). The gene discussed is EGFR; the disease is glioblastoma.